GeneDx Holdings (WGS) Invested Capital (2020 - 2026)

GeneDx Holdings (WGS) has 7 years of Invested Capital data on file, last reported at $354.1 million in Q1 2026.

• Invested Capital for Q1 2026 came in at $354.1 million, up 13.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $354.1 million (up 13.19% YoY), and the FY2025 annual result was $362.7 million, up 44.48% from the prior year.
• Invested Capital eased to $354.1 million in Q1 2026 per WGS's latest filing, from $362.7 million in the prior quarter.
• Over five years, Invested Capital peaked at $648.3 million in Q2 2022 and troughed at $234.3 million in Q4 2023.
• A 5-year average of $334.6 million and a median of $312.9 million in 2025 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2022 and 2023: Invested Capital jumped 214.69% in 2022, then sank 54.48% in 2023.
• A 5-year view of Invested Capital shows it stood at $260.0 million in 2022, then fell by 9.88% to $234.3 million in 2023, then climbed by 7.14% to $251.0 million in 2024, then surged by 44.48% to $362.7 million in 2025, then slipped by 2.37% to $354.1 million in 2026.
• Business Quant data shows WGS's Invested Capital at $354.1 million in Q1 2026, $362.7 million in Q4 2025, and $347.1 million in Q3 2025.